Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWTG.L Regulatory News (WTG)

  • There is currently no data for WTG

Update and Board appointments

12 Jan 2015 07:00

RNS Number : 8481B
Quindell PLC
12 January 2015
 

12 January 2015

Quindell Plc

 

("Quindell" or the "Company" or the "Group")

 

Update and Board appointments

 

Quindell Plc (AIM: QPP.L), provides an update on, inter alia, the year end position of the Group and the search for a permanent Chairman and Board appointments.

 

Board appointments

 

The Company announces that, subject to Solicitors Regulation Authority approval and completion of appointment formalities, Richard Rose will join the Board as non-executive Chairman and Jim Sutcliffe will join as Strategy Director and Deputy Chairman.

 

Pending such regulatory approval regarding their appointment to the Board, both Richard Rose and Jim Sutcliffe will be employed by the Group to build upon the progress already made and to assist the Board, inter alia, in the development of the Group's accounting policies (in conjunction with PwC and the Company's auditors, KPMG), the formulation of the Group's future strategy, and the delivery of the optimal capital structure for the Group.

 

Upon Richard Rose's appointment to the Board, David Currie will step down from his position as interim non-executive Chairman and his role will revert to non-executive director.

 

To supplement the work of Richard Rose and Jim Sutcliffe, the Board has today entered into an agreement to receive consultancy services from BaxterBruce Limited ("BaxterBruce"), a consultancy firm of which Jim Sutcliffe is a Director. In addition to Jim Sutcliffe and Richard Rose, BaxterBruce will utilise its associates Marisa Cassoni and John Tomlins for this engagement with the Company.

 

As part of the remuneration and incentive package agreed with Richard Rose and Jim Sutcliffe, it is the intention of the Board to grant to them options over the Company's Ordinary Shares of 15p each ("Shares"). Richard Rose will receive options over approximately 8.73m Shares and Jim Sutcliffe will receive options over approximately 10.9m Shares. It is the intention of the Board that these options will be granted with exercise prices from 68.65p (being the average middle market quotation of a Share for the last 5 dealing days) up to £3.40 and vesting will occur at intervals spread over the next 12 months. Further details will be included in the announcement made when such options are granted.

 

Trading update

 

Trading in the Group's business remains robust in both Professional Services and Digital Solutionswith management satisfied with case volumes, case settlements and digital solutions revenues. The Group's revenue and earnings are subject to the Independent Review of accounting policies and guidance will be given by the Board following conclusion of the Review. 

 

Operating cash inflow for H2 2014 (before exceptional items but including initiatives that concluded in the period) was approximately £13 million. Cash generation remains a key focus of the Group and initiatives to improve the working capital profile of the Group continue to be pursued. The Board remains comfortable with the Group's overall cash position and, taking into account the Group's cash reserves and continued access to its three credit facilities, believes that the Group's resources are sufficient to deliver on management's current plans. As at 31 December 2014, the Group had gross cash of approximately £69 million and drawn banking facilities of approximately £52 million.

 

Corporate matters

 

As announced on 2 January 2015, the Company has entered into an exclusivity arrangement with a third party in respect of the possible disposal of an operating division of the Group. The Company remains engaged with this party and is also in early discussions with a range of parties interested in exploring possible transactions with the Group relating to a number of its operating businesses but there can be no certainty that any of these discussions will lead to the disposal of any of the Group's assets.

 

Independent Review

 

The Independent Review is ongoing and shareholders will be updated as appropriate. The Board's current expectation is that the review will be completed by the end of February.

 

Commenting on the appointments, David Currie, interim non-Executive Chairman, said:

 

"I am pleased that such a high calibre group of professionals will be helping the Board at this time and that Richard and Jim are expected to join the Board in due course. Richard, Jim, Marisa and John have extensive public company, accounting and sector knowledge and I look forward to working with them and the existing management in completing the Independent Review, acting on its conclusions and in formulating our Group strategy."

 

Robert Fielding, Group Chief Executive, said:

 

"We welcome Richard and Jim to the team; both bring a wealth of experience which will assist the business as we move in to our next phase of development."

 

Information required under paragraph (g) of Schedule 2 of the AIM Rules will be made following final regulatory approval and at the time of the formal appointment of Messrs. Rose and Sutcliffe.

 

 

Background information

 

Richard Rose has extensive public company experience and is currently Chairman of AO World plc, Crawshaw Group plc, Booker Group plc and Anpario Group plc. Richard's previous roles include that of Executive Chairman of Helphire plc, the listed credit hire and legal services / injury claims business (now Redde plc).

 

Jim Sutcliffe has considerable experience in the financial and professional services sector. He is currently Chairman of Sun Life Financial, Canada, Senior Independent Director of Lonmin plc and a non-executive director of Liberty Holdings, South Africa. He is also a non-executive director and Chairman, Codes and Standards Committee of Financial Reporting Council. Previously, Jim has held the position of Chief Executive Officer of Old Mutual PLC and Chief Executive Officer of Prudential UK.

 

Marisa Cassoni is an experienced Finance Director and currently non-executive director of The People's Operator plc, GFI Group Inc, Skipton Building Society and AO World plc. Previously Marisa was the Finance Director of the John Lewis Partnership and prior to that was the Group Finance Director of Royal Mail plc.

 

John Tomlins has spent his entire career working in the IT and financial services sectors, is chairman of a large provider of Wealth Management systems and administration and is a non-executive director of A J Bell Holdings Limited.

 

 

-ends-

 

For further information:

 

Quindell Plc

David Currie, non-executive Interim Chairman

Robert Fielding, Group Chief Executive

Stephen Joseph, Head of Investor Relations

 

Tel: 01489 864200

Cenkos Securities plc, Nominated Adviser and broker

Stephen Keys / Mark Connelly

 

Tel: 020 7397 8900

Bell Pottinger

Victoria Geoghegan / Elizabeth Snow

Tel: 020 3772 2562

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUUAVRVRAAARR
Date   Source Headline
5th Dec 201110:54 amPRNForm 8.3 - Quindell Portfolio Plc
5th Dec 20119:58 amRNSForm 8.3 - Quindell Portfolio Plc
5th Dec 20117:00 amRNSRule 2.10 Announcement
2nd Dec 20111:39 pmRNSEarly settlement of TMS Earnout
2nd Dec 20117:00 amRNSRecommended Share Offer for Mobile Doctors
1st Dec 201110:58 amRNSForm 8.3 - Quindell Portfolio Plc
30th Nov 20112:00 pmRNSTotal Voting Rights
29th Nov 201110:36 amRNSForm 8.3 - Quindell Portfolio Plc
28th Nov 20119:07 amRNSForm 8.3 - Quindell Portfolio Plc
25th Nov 20113:54 pmRNSTMC (Southern) Ltd - Form 8.3 - Quindell
25th Nov 201110:40 amRNSForm 8.3 - Quindell Portfolio Plc
18th Nov 20117:00 amRNSAppointment of Joint Broker
17th Nov 20115:32 pmRNSForm 8 (OPD) Mobile Doctors Group Plc
17th Nov 20114:38 pmRNSJohn Stretton-Knowles - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSMatthew Whiting - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSNeil McGrigor - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSMark Read - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSSimon Rand - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSTony Smith - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSJames Eneas - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSDominic Milton - Form 8.3 - Quindell
17th Nov 20114:38 pmRNSTMC (Southern) Limited - Form 8.3 - Quindell
17th Nov 20114:37 pmRNSBradley Wingrave - Form 8.3 - Quindell
17th Nov 20114:37 pmRNSForm 8 (OPD) (Quindell Portfolio Plc)
17th Nov 20114:37 pmRNSForm 8 (OPD) (Mobile Doctors)
17th Nov 20114:37 pmRNSRule 2.10 Announcement
10th Nov 20117:00 amRNSPartnership with SMI Telecoms LLC
7th Nov 20112:57 pmRNSForm 8.3 - Quindell Portfolio Plc
4th Nov 20119:54 amRNSPossible Offer for Mobile Doctors
1st Nov 20117:00 amRNSAcquisition of Maine Finance Limited
31st Oct 20117:00 amRNSTotal Voting Rights
26th Oct 20117:00 amRNSIntegration of Acquired Businesses
21st Oct 201110:58 amRNSDirector Shareholdings/Significant Shareholders
19th Oct 201110:56 amRNSDirector/PDMR Shareholding
19th Oct 20119:56 amRNSDirector/PDMR Shareholding
19th Oct 20117:00 amRNSFurther Investment in Mobile Doctors Group plc
17th Oct 201110:00 amRNSDirector/PDMR Shareholding
17th Oct 20117:00 amRNSSeven new Contract wins and Trading Update
10th Oct 20117:10 amRNSFurther Investment in Mobile Doctors Group plc
10th Oct 20117:00 amRNSAppointment of Financial PR Advisor
1st Aug 20117:00 amRNSTotal Voting Rights
25th Jul 20117:01 amRNSDirector/PDMR Shareholding
25th Jul 20117:01 amRNSInvestment in MDG.L and Board Appointment
25th Jul 20117:00 amRNSHalf Yearly Report
22nd Jul 20117:00 amRNSAcquisition
21st Jul 20117:00 amRNSInvestment in digital insurance brand Ingenie
18th Jul 20117:00 amRNSChange of Name
14th Jul 201111:24 amRNSIssue of Warrants
14th Jul 201111:23 amRNSResults of General Meeting
11th Jul 20114:02 pmRNSChanges to significant shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.